Head & Consultant
Radiation Oncologist
Proton Therapy SG
Singapore Institute of Advanced Medicine

Email: wenshen.looi@proton.sg
H/P: +65 92975542 (WhatsApp Only)

Visiting Consultant Radiation Oncologist
KK Women’s and Children’s Hospital, Singapore

Visiting Consultant Radiation Oncologist
National Cancer Centre Singapore

• Particle Therapy Cooperative Group (PTCOG) Genitourinary Subcommittee Member
• Children’s Oncology Group Member
• USA UFPTI Proton Fellowship-Trained

Conditions Treated:

• Urologic- prostate and kidney 
• Sarcomas
• Head and neck
• Liver cancer
• Paediatric Cancer

Contact: WhatsApp +65 9297 5542 or email wenshen.looi@proton.sg.

Biography:

Dr Looi Wen Shen is a radiation oncologist at Proton Therapy SG, Singapore Institute of Advanced Medicine. He graduated from Yong Loo Lin School of Medicine, National University of Singapore in 2008, and went on to complete his residency training in National Cancer Centre Singapore (NCCS), before receiving specialist accreditation in radiation oncology by the Specialist Accreditation Board. He worked as a Consultant in the Division of Radiation Oncology, National Cancer Centre Singapore; Clinical Assistant Professor in Duke-NUS medical school; and Clinical Teacher in the Lee Kong Chian School of Medicine. During his time in public service in NCCS, Dr Looi oversaw the creation of a comprehensive paediatric radiation oncology program that integrated allied healthcare to improve patient satisfaction and experience. As an educator to the younger generation of doctors, Dr Looi obtained a certificate for Essential Skills in Medical Education (ESME) for this.

He is a member of the Particle Therapy Cooperative Group (PTCOG) Genitourinary Subcommittee, which is involved in developing proton beam therapy internationally. His clinical interests in prostate cancer include stereotactic body radiotherapy (SBRT) for both the prostate primary as well as metastases. His latest project is the implementation of stereotactic body proton therapy (SBPT) for prostate cancer, which will combine the precision of both SBRT and proton therapy.

Dr Looi is a radiation oncologist with practical overseas experience in proton therapy, having practised at the University of Florida Proton Therapy Institute, USA, where he completed subspecialty fellowship training in proton therapy and paediatric radiotherapy as an Adjunct Clinical Post-Doctoral Associate. He also received further proton therapy training at the Taiwan Medical University Hospital Proton Centre for regionally endemic diseases such as liver cancer and nasopharyngeal cancer. He is adept at 3D conformal radiotherapy (3DCRT), intensity modulated radiotherapy (IMRT), volumetric modulated arc therapy (VMAT), stereotactic body radiotherapy (SBRT), and intensity modulated proton therapy (IMPT).

Dr Looi is proud to have been able to kick start the paediatric proton program at National Cancer Centre Singapore. Today, Dr Looi continues to contribute to public healthcare as a Visiting Consultant in KK Women’s and Children’s Hospital and National Cancer Centre Singapore. Dr Looi is one of the few regional radiation oncologist members of the Children’s Oncology Group (COG). Additionally, he is listed in the Chordoma Foundation Directory (Wen Shen Looi). He is also a member of several other professional societies including the American Society for Radiation Oncology (ASTRO), Academy of Medicine, Singapore (AMS), Royal College of Radiology (RCR) (UK), Children’s Cancer and Leukaemia Group (CCLG) (UK), and the Paediatric Radiation Oncology Society (PROS).

While in NCCS, his research was published in journals such as the International Journal of Radiation Oncology Biology and Physics, and Medical Physics, Pediatric Blood and Cancer, and the Archives of Disease in Childhood. Through his research, Dr Looi endeavours to decrease the acute and late side effects of radiation in patients, thus improving their quality of life. Dr Looi will continue his research in the Singapore Institute of Advanced Medicine (SAM), focusing on the clinical outcomes of proton therapy. SAM’s plans for incorporation of FLASH proton therapy will also add an exciting dimension to the local proton research and clinical scene.

Publications:

Please see Google Scholar